Oscar Health, Inc. (NYSE:OSCR) Receives Consensus Recommendation of “Reduce” from Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCR) have been given an average rating of “Reduce” by the five research firms that are covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating on the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $16.50.

A number of research analysts recently weighed in on OSCR shares. Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price target for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Wall Street Zen lowered shares of Oscar Health from a “buy” rating to a “hold” rating in a research report on Sunday, June 8th. Finally, Piper Sandler lowered their price objective on shares of Oscar Health from $25.00 to $18.00 and set an “overweight” rating on the stock in a research report on Monday, June 9th.

Insiders Place Their Bets

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company’s stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the sale, the director now directly owns 64,512 shares in the company, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 24.39% of the company’s stock.

Institutional Trading of Oscar Health

Institutional investors have recently modified their holdings of the business. Jones Financial Companies Lllp lifted its stake in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares in the last quarter. Strs Ohio purchased a new stake in Oscar Health in the 1st quarter worth approximately $30,000. Larson Financial Group LLC lifted its stake in Oscar Health by 83,733.3% in the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock worth $33,000 after purchasing an additional 2,512 shares in the last quarter. CWM LLC lifted its stake in Oscar Health by 50.7% in the 1st quarter. CWM LLC now owns 3,204 shares of the company’s stock worth $42,000 after purchasing an additional 1,078 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd lifted its stake in Oscar Health by 484.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company’s stock worth $45,000 after purchasing an additional 2,854 shares in the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Stock Down 2.7%

OSCR opened at $13.95 on Wednesday. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The company’s 50-day moving average is $14.03 and its 200 day moving average is $14.45. Oscar Health has a fifty-two week low of $11.20 and a fifty-two week high of $23.79. The firm has a market capitalization of $3.55 billion, a P/E ratio of -697.10 and a beta of 1.73.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $0.09. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The company had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. During the same period last year, the firm earned $0.62 earnings per share. The firm’s revenue was up 42.2% on a year-over-year basis. Research analysts expect that Oscar Health will post 0.69 earnings per share for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.